Latest Articles, News & Analysis on recall | Livewire

Equities

December 05, 2023 07:45

Why this ASX medtech stock is dominating the competition

How ResMed is steadily becoming a more dominant player in the global OSA duopoly

Jacob Celermajer

Jacob Celermajer

Cordis Asset Management

December 05, 2023 07:45

1

most popular

Equities

Worried about a downturn? Here are 7 ASX companies with resilient earnings

Sara Allen,

Livewire Markets

Equities

Don't let all time highs stop you buying this "bull" market

Michael Carmody,

Centennial Asset Management

Equities

The US$115 billion question: Will Meta and Microsoft's huge spending on AI be worth it?

Hans Lee,

Livewire Markets

Funds

If 24 LICs ran the Melbourne Cup, which would be our favourites

Daryl Wilson,

Affluence Funds Management

view all

Advertisement